AbbVie Seeks EMA Approval for Subcutaneous Risankizumab in Crohn's Disease Treatment #United_States #Crohn's_Disease #AbbVie #North_Chicago #Risankizumab

AbbVie Seeks EMA Approval for Subcutaneous Risankizumab in Crohn's Disease Treatment #United_States #Crohn's_Disease #AbbVie #North_Chicago #Risankizumab